Atacand-hctz is a brand name for a combination of two medical preparations: hydrochlorothiazide and candesartan. The former is a thiazide diuretic that reduces the process of salt absorbation thus preventing harmful fluid retention. As for the latter, it is one of the angiotensin II receptor antagonists that does not allow the blood vessels to narrow, thus decreasing blood pressure and generally improving blood flow. This combination often provides incredible results in high blood pressure treatment.
There are cases where Atacand-hctz must be used with caution, including the patient passing special tests before therapy begins and the doctor adjusting the dose several times. Such a need arises when the patient has congestive heart failure, problems with the potassium, cholesterol, or triglyceride levels in the blood, kidney or liver diseases, asthma, gout, lupus, diabetes.
Note that Atacand-hctz belongs to FDA pregnancy category D. The combination of hydrochlorothiazide and candesartan can cause injury and even death to the unborn child, especially if used in the second and third trimesters. Use at least two forms of birth control during the treatment regimen; if you become pregnant still, tell your doctor right away.
